Skip to content

Rabbit Antiserum to Human IgA

by Dako Corp. 510(k)

Active United States

510(k) K831909

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK831909 Date18 Jul 1983ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 5 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
CZN
Device Class
Class II
Regulation
21 CFR Part 866.5510
Advisory Committee
Immunology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is a rabbit antiserum to human IgA, classified as an immunoglobulin reagent under regulatory nomenclature. It is designed for use in immunohistochemistry to detect human IgA in tissue samples, aiding in diagnostic evaluation of conditions involving IgA deposition or deficiency. The antiserum is produced from rabbit-derived antibodies and is intended for laboratory use in identifying IgA antigens in paraffin-embedded sections.

The product is supplied as a non-conjugated antiserum and is intended for single-use in vitro diagnostic applications. It is regulated under FDA 510(k) clearance (K831909) and falls under product code CZN, with a decision date of July 18, 1983. Sterility and storage conditions are not specified in the regulatory data, but it is classified as a Class II medical device under the FDA’s regulatory framework. No additional regulatory approvals beyond the 510(k) clearance are referenced.

Other devices from Dako Corp.

See all devices from Dako Corp. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the rabbit antiserum to human IgA used for?

    This antiserum is designed for use in immunohistochemistry to detect human IgA antigens in tissue samples. It helps clinicians evaluate conditions involving IgA deposition, such as certain autoimmune diseases or deficiencies, by identifying the presence of IgA in paraffin-embedded sections during laboratory testing.

  • How is the rabbit antiserum to human IgA supplied?

    The product is supplied as a non-conjugated antiserum, meaning it is not pre-linked to a fluorescent or enzymatic marker. It is intended for single-use in vitro diagnostic applications, ensuring each vial is used once for accurate and reliable testing in laboratory settings.

  • Is the rabbit antiserum to human IgA sterile?

    The regulatory data does not explicitly specify sterility requirements for this product. However, as a Class II medical device regulated under FDA 510(k) clearance, it is expected to meet general industry standards for sterility in laboratory reagents. Always follow manufacturer guidelines for handling and storage to ensure safety.

  • Can this antiserum be reused?

    No, this rabbit antiserum to human IgA is intended for single-use only. Reusing the product could compromise accuracy and reliability in detecting IgA in tissue samples, potentially leading to incorrect diagnostic results. Each vial should be used once and discarded.

  • What regulatory approval does this device hold?

    The rabbit antiserum to human IgA holds an FDA 510(k) clearance under the reference number K831909, classified under product code CZN. This clearance indicates that the device is substantially equivalent to a legally marketed predicate device and meets FDA requirements for safety and effectiveness in its intended use for immunohistochemistry.